SM
CNMD icon

SLS Management’s CONMED CNMD Stock Holding History

SLS Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-96,001
Closed -$4.58M – 12
2016
Q2 		$4.58M Buy
96,001
+900
+0.9% +$38.1K 10.06% 3
2016
Q1 		$3.99M Buy
+95,101
New +$3.73M 6.65% 5

Other funds holding CNMD

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SLS Management's CNMD Position: Q3 2016 in Review

SLS Management sold out of CONMED (CNMD) in Q3 2016, closing a stake of 96,001 shares — an estimated $4.58M sold.

SLS Management first reported a position in CNMD in Q1 2016 and held it in 2 quarters. The position peaked at $4.58M in Q2 2016. 145 funds tracked by Wall St. Rank hold CNMD as of Q3 2016.

  • SLS Management reported no remaining CONMED position as of Q3 2016 after selling out during the quarter.
  • SLS Management sold 96,001 CONMED shares in Q3 2016, an estimated $4.58M.
  • SLS Management first reported a position in CONMED in Q1 2016 and held it in 2 quarters.
  • SLS Management's CONMED position peaked at $4.58M in Q2 2016.
  • 145 funds tracked by Wall St. Rank held CONMED as of Q3 2016.

Based on SLS Management's 13F filing for Q3 2016, filed 14 Nov 2016.